Menu
GeneBe

SOST

sclerostin, the group of DAN family

Basic information

Region (hg38): 17:43753737-43758791

Links

ENSG00000167941NCBI:50964OMIM:605740HGNC:13771Uniprot:Q9BQB4AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • sclerosteosis 1 (Strong), mode of inheritance: AR
  • craniodiaphyseal dysplasia (Supportive), mode of inheritance: AD
  • sclerosteosis (Supportive), mode of inheritance: AR
  • hyperostosis corticalis generalisata (Supportive), mode of inheritance: AD
  • craniodiaphyseal dysplasia, autosomal dominant (Limited), mode of inheritance: Unknown
  • sclerosteosis 1 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Craniodiaphyseal dysplasia, autosomal dominant; Sclerosteosis 1; van Buchem diseaseAD/ARMusculoskeletalStarting in infancy, regular surveillance for sequelae related to overgrowth, including hearing evaluation, assessment of signs of increased intracranial pressure and cranial nerve entrapment, can allow early surgical managementAudiologic/Otolaryngologic; Craniofacial; Musculoskeletal13924477; 3276528; 6323069; 8433139; 9712543; 9463328; 11179006; 11836356; 12116252; 12694228; 14671168; 17245025; 17853455; 20301406; 20583295; 21221996

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SOST gene.

  • Sclerosteosis 1 (48 variants)
  • not provided (18 variants)
  • Inborn genetic diseases (11 variants)
  • Primary bone dysplasia with increased bone density (5 variants)
  • SOST-related condition (2 variants)
  • not specified (1 variants)
  • Craniodiaphyseal dysplasia, autosomal dominant (1 variants)
  • - (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SOST gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
6
clinvar
8
missense
1
clinvar
20
clinvar
1
clinvar
1
clinvar
23
nonsense
1
clinvar
1
clinvar
2
start loss
0
frameshift
1
clinvar
1
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
17
clinvar
4
clinvar
9
clinvar
30
Total 2 2 39 11 10

Variants in SOST

This is a list of pathogenic ClinVar variants found in the SOST region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-43753813-A-G Sclerosteosis 1 Uncertain significance (Jan 13, 2018)323425
17-43753844-C-T Sclerosteosis 1 Uncertain significance (Jan 13, 2018)888823
17-43753917-A-C Primary bone dysplasia with increased bone density Uncertain significance (Jun 14, 2016)323426
17-43753937-GC-G Primary bone dysplasia with increased bone density Benign (Jun 14, 2016)323427
17-43753940-A-C Sclerosteosis 1 Uncertain significance (Jan 13, 2018)890522
17-43753948-G-C Sclerosteosis 1 Benign (Jan 12, 2018)323428
17-43753951-C-G Sclerosteosis 1 Likely benign (Jan 12, 2018)890523
17-43753979-G-A Sclerosteosis 1 Uncertain significance (Jan 13, 2018)890524
17-43753993-CT-C Primary bone dysplasia with increased bone density Benign (Jun 14, 2016)323429
17-43754075-G-C Sclerosteosis 1 Uncertain significance (Jan 12, 2018)890525
17-43754075-G-GC Primary bone dysplasia with increased bone density Benign (Jun 14, 2016)323430
17-43754166-T-C Sclerosteosis 1 Uncertain significance (Jan 13, 2018)323431
17-43754279-G-A Sclerosteosis 1 Uncertain significance (Jan 13, 2018)890526
17-43754338-C-T Sclerosteosis 1 Benign (Jan 13, 2018)323432
17-43754440-A-G Sclerosteosis 1 Uncertain significance (Jan 12, 2018)891082
17-43754459-T-A Sclerosteosis 1 Uncertain significance (Jan 12, 2018)891083
17-43754476-G-A Sclerosteosis 1 Benign (Aug 23, 2019)323433
17-43754653-A-G Sclerosteosis 1 Uncertain significance (Jan 13, 2018)891084
17-43754676-A-G Sclerosteosis 1 Uncertain significance (Jan 13, 2018)891085
17-43754773-C-A Sclerosteosis 1 Uncertain significance (Jan 13, 2018)891086
17-43754780-C-T Sclerosteosis 1 Benign (Jan 13, 2018)323434
17-43755022-G-A Sclerosteosis 1 Benign (Jan 13, 2018)892296
17-43755028-G-C Sclerosteosis 1 Uncertain significance (Jan 12, 2018)323435
17-43755120-T-C Sclerosteosis 1 Likely benign (Jan 13, 2018)892297
17-43755123-A-G Sclerosteosis 1 Uncertain significance (Jan 13, 2018)892298

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SOSTprotein_codingprotein_codingENST00000301691 25058
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.8670.131125744031257470.0000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8351061330.7960.000007451331
Missense in Polyphen3444.0020.77269426
Synonymous0.04686262.50.9920.00000378453
Loss of Function2.3806.600.002.84e-771

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001870.0000176
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation. {ECO:0000269|PubMed:15908424}.;
Disease
DISEASE: Van Buchem disease (VBCH) [MIM:239100]: VBCH is an autosomal recessive sclerosing bone dysplasia characterized by endosteal hyperostosis of the mandible, skull, ribs, clavicles, and diaphyses of the long bones. Affected patients present a symmetrically increased thickness of bones, most frequently found as an enlarged jawbone, but also an enlargement of the skull, ribs, diaphysis of long bones, as well as tubular bones of hands and feet. The clinical consequence of increased thickness of the skull include facial nerve palsy causing hearing loss, visual problems, neurological pain, and, very rarely, blindness as a consequence of optic atrophy. Serum alkaline phosphatase levels are elevated. {ECO:0000269|PubMed:11836356}. Note=The disease is caused by mutations affecting the gene represented in this entry. A 52 kb deletion downstream of SOST results in SOST transcription suppression causing van Buchem disease.; DISEASE: Craniodiaphyseal dysplasia autosomal dominant (CDD) [MIM:122860]: A severe bone dysplasia characterized by massive generalized hyperostosis and sclerosis, especially involving the skull and facial bones. The sclerosis is so severe that the resulting facial distortion is referred to as 'leontiasis ossea' (leonine faces) and the bone deposition results in progressive stenosis of craniofacial foramina. Respiratory obstruction due to choanal stenosis compromises the clinical outcomes of affected patients. {ECO:0000269|PubMed:21221996}. Note=The disease is caused by mutations affecting the gene represented in this entry. Heterozygous mutations located in the secretion signal of the SOST gene prevent sclerostin secretion and can be responsible for craniodiaphyseal dysplasia.;
Pathway
Wnt signaling pathway - Homo sapiens (human);Role of Osx and miRNAs in tooth development;Wnt Signaling Pathway;Signaling by WNT;Signal Transduction;Negative regulation of TCF-dependent signaling by WNT ligand antagonists;TCF dependent signaling in response to WNT (Consensus)

Recessive Scores

pRec
0.405

Haploinsufficiency Scores

pHI
0.477
hipred
Y
hipred_score
0.831
ghis
0.453

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.283

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sost
Phenotype
normal phenotype; skeleton phenotype; limbs/digits/tail phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype;

Gene ontology

Biological process
ossification;response to mechanical stimulus;Wnt signaling pathway;negative regulation of ossification;negative regulation of BMP signaling pathway;negative regulation of protein complex assembly;positive regulation of transcription, DNA-templated;cellular response to parathyroid hormone stimulus;negative regulation of canonical Wnt signaling pathway
Cellular component
extracellular region;extracellular space;Golgi apparatus;protein-containing complex;collagen-containing extracellular matrix
Molecular function
protein binding;transcription factor binding;heparin binding